Antifungal Liquid

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Antifungal Liquid
Generic name: TOLNAFTATE
Manufacturer: Premier Brands of America Inc
Product type: HUMAN OTC DRUG
SPL set ID: 2644ba07-aaee-6402-e063-6394a90a2827
SPL ID: 3bb9fc56-4b58-0d7e-e063-6394a90a56cc
Version: 2
Effective date: 2025-08-06
Source export date: 2026-11-06
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/db89d5ebfc3e02f44e8769334d799cd3436b05f779823ab00297f1f800c89ddf/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:39:43

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		Antifungal Liquid	openfda.brand_name
generic name		TOLNAFTATE	openfda.generic_name
manufacturer name		Premier Brands of America Inc	openfda.manufacturer_name
ndc	package	56104-902-01	openfda.package_ndc
ndc	product	56104-902	openfda.product_ndc
ndc11	package	56104090201	derived:openfda.package_ndc
rxcui		313423	openfda.rxcui
spl id		3bb9fc56-4b58-0d7e-e063-6394a90a56cc	id
spl set id		2644ba07-aaee-6402-e063-6394a90a2827	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Do not use on children under 2 years of age unless directed by a doctor. When using this product avoid contact with the eyes. Stop use and consult a doctor if irritation occurs there is no improvement within 4 weeks Keep out of reach of children. If accidental ingestion occurs, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.